drugset / Trial / NCT00311779

A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis

NCT00311779

Phase 2 Completed 120 enrolled ParaPRO LLC
RandomizedFactorialSingle-blindTreatment

Summary

The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice).

Timeline

Start
2006-03
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Spinosad Small molecule 0.5 % Topical
Subject Spinosad Small molecule 1 % Topical